Asciminib for CML: same target, new arrow

Blood. 2021 Nov 25;138(21):2009-2010. doi: 10.1182/blood.2021013257.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Niacinamide* / analogs & derivatives
  • Pyrazoles*

Substances

  • Pyrazoles
  • asciminib
  • Niacinamide